VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 5.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79 | -100.0% | 18,220 | -19.2% | 0.01% | -73.3% |
| Q1 2022 | $255,000 | -53.1% | 22,541 | -35.0% | 0.03% | -50.0% |
| Q4 2021 | $544,000 | +37.7% | 34,681 | +31.9% | 0.06% | +33.3% |
| Q1 2021 | $395,000 | +237.6% | 26,293 | +132.9% | 0.04% | +95.7% |
| Q1 2020 | $117,000 | -58.5% | 11,287 | -34.4% | 0.02% | -48.9% |
| Q4 2019 | $282,000 | +59.3% | 17,193 | +29.1% | 0.04% | +45.2% |
| Q3 2019 | $177,000 | -33.5% | 13,320 | -7.9% | 0.03% | -29.5% |
| Q1 2019 | $266,000 | +9.9% | 14,457 | +0.9% | 0.04% | +22.2% |
| Q1 2018 | $242,000 | -12.9% | 14,325 | -7.7% | 0.04% | -20.0% |
| Q3 2017 | $278,000 | -17.0% | 15,521 | -24.3% | 0.04% | -28.6% |
| Q2 2017 | $335,000 | +70.9% | 20,510 | +46.3% | 0.06% | +37.0% |
| Q1 2017 | $196,000 | -22.8% | 14,023 | -8.2% | 0.05% | -32.4% |
| Q3 2016 | $254,000 | -35.5% | 15,276 | -56.3% | 0.07% | -49.3% |
| Q3 2015 | $394,000 | +162.7% | 34,928 | +196.0% | 0.13% | +157.7% |
| Q2 2015 | $150,000 | – | 11,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |